Holders

XTL BIOPHARMACEUTICALS LTD

Q1 2025 13F holders

CUSIP
98386D307
Type
Equity
Class
SPONSORED ADR NE
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Shares Option type